The House today passed that would suspend through 2022 tariffs on certain infant formula base powders used to make infant formula in the United States. Congress in July passed legislation (H.R.8351) suspending tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a  to help health care providers and families locate formula.
 

Related News Articles

Headline
The House committees with jurisdiction over Medicaid and other health care programs have announced they will begin marking up their portions of the budget鈥
Headline
The AHA May 8 voiced support for the Save Healthcare Workers Act to House and Senate sponsors of the legislation. The bipartisan bill would make it a federal鈥
Headline
President Trump today released his discretionary spending budget blueprint for fiscal year 2026. The 鈥渟kinny budget鈥 request, which includes top line鈥
Headline
The House Energy and Commerce Committee held a markup April 29 where it advanced the AHA-supported SUPPORT Act (H.R. 2483). The legislation would reauthorize鈥
Perspective
Public
Congressional lawmakers are heading home for a two-week district work period after both the Senate and House passed a revised budget resolution for fiscal year鈥
Headline
Story Updated April 5 at 8:30 a.m. ETThe Senate by a vote of 51 to 48 passed its revised budget resolution for fiscal year 2025 with Sens. Rand鈥